Sarepta Gains After Pfizer DMD Gene Therapy Data Fall Short

(Bloomberg) -- Pfizer Inc.’s experimental gene therapy for Duchenne muscular dystrophy helped boys with the deadly disease, but failed to match benefits previously shown by competitor Sarepta Thera...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.